Frazier Healthcare Partners

Frazier Healthcare Partners is a healthcare-focused private equity and venture capital firm operating across two distinct investment strategies: Growth Buyout and Life Sciences. The Growth Buyout strategy targets profitable, lower middle-market healthcare companies with EBITDA of $5 million to $50 million across healthcare services, pharmaceutical services, medical products, biopharmaceutical services, medical and clinical trial services, and drug development providers in the United States and Canada, committing equity of $30 million to $350 million per transaction through buyouts, recapitalizations, and corporate carve-outs, with majority control as the standard ownership structure. The Life Sciences strategy invests in private and public biopharmaceutical companies across three sub-approaches: company formation (through academic institution and pharmaceutical company relationships), early-stage venture capital, and late-stage private and public market investments in companies addressing unmet medical needs. Founded in 1991 by Alan D. Frazier, the firm is headquartered in Seattle, Washington, United States, with additional offices in New York, New York, and Menlo Park, California.